Skip to content
Search

Latest Stories

CCA calls PDA's pharmacy closure allegation 'highly inflammatory'

All pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies, clarified the Company Chemists’ Association (CCA) in response to an attack by the Pharmacists' Defence Association.

Last week, PDA allegedly accused some large pharmacy chains of 'orchestrating' full or part-time closures of some of their shops due to the staff shortage.


In its Open Letter published on Tuesday (July 19), PDA demanded urgent action “to protect patients by ensuring that essential community pharmacy services are provided safely and consistently”.

“All parts of the healthcare system are struggling to recruit staff and to assume that pharmacies would be immune to such pressures, seems fanciful,” said CCA.

“CCA members are working extraordinarily hard to prevent temporary closures, but recruitment and retention of pharmacists is becoming increasingly tough. The recent rise in Covid cases and the beginning of the summer holiday season in parts of the UK have only worsened the situation.”

The Association also showed data from the PSNC Pharmacy Pressures Survey (April 2022) which found that 91 per cent of pharmacies are experiencing staff shortages, clearly demonstrating that these shortages are affecting the entire sector.

“To accuse some pharmacy businesses of choosing to act with impunity, to restrict patients’ access to NHS funded services is highly inflammatory. The truth of the matter is that all pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies,” opines CCA.

It added: “Mark Koziol heard first hand from contractors of all sizes at the recent APPG inquiry, of the difficulties they are facing in finding pharmacists and technicians to allow them to open.”

“For him to deny what is plain to see is unbelievable and quite frankly insulting to all those frontline professionals who need the support that can only come from a co-ordinated approach to addressing workforce shortages across the whole of primary care.”

“We are extremely concerned that the PDA see fit to accuse large pharmacy operators of looking to misdirect healthcare systems into believing that the shortage of pharmacists being felt across the UK is a façade, being used to influence regulatory change.”

“This is categorically untrue. We believe that it is the PDA who are misleading government officials into believing that there is not a workforce crisis, in a vain attempt to continue to drive up the cost of providing healthcare across the UK.

It has been reported in the press that the NHS’s need to fund increased costs from within existing health budgets will mean having to release money from other planned frontline services.”

“We will continue to work with NHSE and DHSC to establish the facts about the scale of the workforce crisis across the UK and to find ways to make sure that the needs of all parts of primary care can be met, both in the short and longer term.”

PDA chair Koizol, who wrote the letter, went on to allege that many of those closure were “being orchestrated”.

He wrote that the “pharmacist shortage” narrative cited as a reason for these closures was “very different” from “the reality experienced by our members”, including both employed and locum pharmacists.

“We have evidence to show that these closures are being announced up to four weeks in advance."

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less